Regulatory Story
Go to market news section View chart   Print
RNS
Brunner Investment Trust PLC   -  BUT   

Half-year Report

Released 07:00 18-Jul-2019

RNS Number : 9018F
Brunner Investment Trust PLC
18 July 2019
 

 

                                                                                                                           17 July 2019

 

THE BRUNNER INVESTMENT TRUST PLC

HALF-YEARLY FINANCIAL REPORT

For the six months ended 31 May 2019

 

Highlights

 

·      Net asset value (debt at fair value) per share up by +1.8% (2018: +3.1%)

·      Net asset value (debt at par) per share up by +2.6% (2018: +2.4%)

·      Earnings per ordinary share 12.6p (2018: 10.6p) +18.9%

·      Dividends for the half year 9.32p1 (2018: 8.1p) +15.1%

·      Net asset value total return (debt at fair value) per share up by +2.9% (2018: +4.0%)

·      Net asset value total return (debt at par) per share up by +3.7% (2018: +3.4%)

·      Share price up by 3.9% to 774.0p (2018: 745.0p)

·      Discount of net asset value (debt at fair value) to share price 10.1% and an average of 9.6% over the period (2018: 11.9%, average over the year 9.5%) 

·      Benchmark Index increased by 3.4% (2018: +4.5%)

 

 

 

Revenue

Six months ended

31 May 2019

Six months ended

31 May 2018

 

%

change

 

Available for ordinary dividend

£5,372,000

£4,502,000

 

+19.3

Earnings per ordinary share

12.6p

10.6p

 

+18.9

Quarterly dividends per ordinary share

 

9.32p1

 

8.1p

 

+15.1

Retail price index

289.2

280.7

 

+3.0

 

 

 

 

 

1First quarterly 4.66p, second quarterly 4.66p

 

 

 

 

 

 

 

 

 

Assets

 

At 31 May

2019

At 30 Nov

2018

 

%

change

Net asset value per ordinary share

(debt at fair value)

861.2p

845.8p

 

+1.8

Net asset value per ordinary share (debt at par)

865.8p

843.9p

 

+2.6

Ordinary share price

774.0p

745.0p

 

+3.9

Total net assets (debt at fair value)

£367,656,000

£361,105,000

 

+1.8

Total net assets (debt at par)

£369,616,000

£360,273,000

 

+2.6

 

 

 

 

 

Performance relative to the benchmark for the six months to 31 May 2019

 

Net Asset Value with debt at fair value relative to Benchmark*

 

 

 

Capital Return

 

Total Return2

 

 

 

 

 

Change in net asset value

 

 

1.8%

2.9%

Change in benchmark

 

 

1.7%

3.4%

 

 

 

 

 

Percentage point performance against benchmark*

 

 

0.1

-0.5

 

 

 

 

 

                 

 

 

*The benchmark applied is 70% FTSE World Ex UK Index and 30% FTSE All-Share Index.

 

2 Total returns are calculated with net dividends reinvested

 

 

 

 

 

Reconciliation of Benchmark performance to total return to shareholders

 

 

 

 

 

 

Equity portfolio return (excluding cash)

 

 

4.1%

 

 

 

 

 

 

Impact of gearing

 

 

0.2%

 

Finance costs

 

 

-0.1%

 

Increase in fair value of debt

 

 

-0.8%

 

 

 

 

 

 

Effect of gearing

 

 

-0.7%

 

 

 

 

 

 

Management fee

 

 

-0.2%

 

Administration expenses

 

 

-0.1%

 

Other

 

 

-0.2%

 

Total of above factors

 

 

-0.5%

 

 

 

 

 

 

Return to shareholders

 

 

2.9%

 

Change in benchmark

 

 

3.4%

 

Relative performance

 

 

       -0.5

 

 

 

 

 

 

 

 

Interim Management Report

 

Performance

The Net Asset Value per ordinary share of the company increased by 2.9% on a total return basis; the difference between this and the portfolio return of 4.1% is explained in the table above. The benchmark (70% FTSE Word Index Ex UK and 30% FTSE All-Share Index) rose by 3.4% over the period.

 

Earnings

Earnings increased by 18.9% to 12.6p per ordinary share in the six months to 31 May 2019 (2018: 10.6p).

 

Dividends

In continuation of the policy to distribute income more evenly throughout the year, the board declared a first quarterly dividend of 4.66p per ordinary share which is payable on 25 July 2019.  The board has now declared a second quarterly dividend of 4.66p per ordinary share payable on 19 September 2019 to holders on the register of members at the close of business on 9 August 2019.  A Dividend Reinvestment Plan (DRIP) is available for this dividend and the relevant Election Date is 23 August 2019.

 

The board is continuing to balance quarterly payments to bring them in line with the final.  It is anticipated, subject to there being no unforeseen circumstances, that the third quarterly dividend will be maintained at this rate, and an unchanged final dividend of 6.00p will be proposed for the year ending 30 November 2019, giving a dividend for the year of 19.98p, a 10% increase on the previous year. The third quarterly payment will be made in December and the final dividend will be proposed for payment in March 2020.

 

Material events and transactions

In the six month period ended 31 May 2019 the following material events and transactions have taken place.

 

·      At the annual general meeting of the company held on 4 April 2019, all the resolutions put to shareholders were passed.

 

There were no share buy backs, share issuances and no related party transactions in the period or since the period end.

 

Principal Risks     

The principal risks facing the company over the next six months are broadly unchanged from those described in the Annual Financial Report for the year ended 30 November 2018. These are set out in a table in the Strategic Report on page 16 of the annual report, together with commentary on the board's approach to mitigating the risks, under the following headings: Portfolio Risk; Business Risk; and Operational Risk. 

 

In addition to the principal risks, the company faces the risks associated with the provision of services by third parties and general business risks including accounting, legal and regulatory matters. The board oversees a  detailed review of the principal risks by the audit committee at least twice a year to ensure the risk assessment is current and relevant, adjusting mitigating factors and procedures as  appropriate.

 

Going concern

The directors believe it is appropriate to continue to adopt the going concern basis in preparing the financial statements as the assets of the company consist mainly of securities which are readily realisable and accordingly, the company has adequate financial resources to continue in operational existence for the foreseeable future.

 

Responsibility Statement

The directors confirm to the best of their knowledge that:

 

·      The condensed set of financial statements contained within the half-yearly financial report has been prepared in accordance with FRS 102 and FRS 104, as set out in Note 2, and the Accounting Standards Board's Statement 'Half-Yearly Financial Reports'; and

 

·      The interim management report includes a fair review of the information required by Disclosure and Transparency Rule 4.2.7 R of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements, and a description of the principal risks and uncertainties for the remaining six months of the financial year; and

 

·      The interim management report includes a fair review of the information concerning related parties transactions as required by the Disclosure and Transparency Rule 4.2.8 R.

 

 

The half-yearly financial report was approved by the board on 17 July 2019 and the above responsibility statement was signed on its behalf by the Chairman.

 

 

Carolan Dobson

Chairman

 

 

Enquiries:

 

For further information, please contact:

 

Allianz Global Investors GmbH, UK Branch

Stephanie Carbonneil

Head of Investment Trusts

Tel: 020 3246 7256

 

 

 

Investment Manager's Review

 

Market Review

Our expectation for the equity market to provide moderate returns with higher volatility has been borne out in the past six months. Overall, global equity markets as measured by the MSCI All Country World Index, are up 3 per cent in GBP terms over the period. However, this modest return has encompassed a sharp correction followed by a rapid recovery. In May, markets experienced yet another, albeit more modest, correction.

 

The catalysts for this increased volatility have been US trade and monetary policy. Escalating trade tensions between the US and its trading partners and the potential impact on global growth have been a major source of concern. At the end of 2018, data revealed that President Trump's tariffs were starting to create a material economic drag. However, promising trade talks soon erased the equity market's losses and sustained markets for some months. Market sentiment was dented once more in May, with both the US and China imposing higher tariffs on each other's exports. Technology stocks were particularly hit after the US administration effectively banned US companies from using equipment made by China's Huawei, raising fears that Beijing would target US tech companies in return.

 

The US Federal Reserve's (Fed) about turn in policy has been the other defining influence on all asset markets. Over the period, the central bank has gone from raising interest rates and pursuing quantitative tightening to pausing and hinting at lower interest rates. This has led to a fall in bond yields and support for bond proxy investments in the equity markets. Against a background of weakening global growth and slumping financial markets, the Fed announced it would not raise rates for the remainder of 2019, and slowed the pace of its balance sheet reductions. Similarly, the European Central Bank (ECB) pledged to hold rates until the end of 2020 and reinstated its offer of cheap long-term loans to banks. The People's Bank of China also injected a record amount of liquidity into China's economy and cut the reserve requirement ratio for banks.  

 

At a sector level, Real Estate, Utilities and Information Technology have made the most impressive gains. The latter has continued to demonstrate its ability to generate meaningful earnings growth amidst market volatility. Meanwhile, Real Estate and Utilities have benefited from lower bond yields.  Conversely, Health Care has come under consistent pressure as Democratic nominees for the US Presidency push for greater state medical provision.

 

In terms of currencies, sterling has remained a Brexit bellwether, consistently reflecting investors' fluctuating concerns over the likelihood, timing and nature of the UK's exit from the European Union (EU). As a result, sterling strengthened steadily until March, in line with the prospects of either a soft Brexit or second referendum. Since then, the currency has weakened to December levels, reflecting Theresa May's departure and the likelihood of her being replaced by Boris Johnson, who is more vocal about leaving the EU without a deal.  

 

Portfolio Review

Between December 2018 and May 2019 inclusive, the Trust's portfolio returned 4.1 per cent against a benchmark return of 3.4 per cent. The main driver of performance over this period has been stock selection. Holdings in the Consumer Goods, Utilities and Financials sectors have all contributed positively to returns.

 

Adidas, the maker of sports apparel, has made the strongest contribution to the portfolio. Its CEO, Kasper Rorsted, has made clear cultural and operational changes to the company, and these continue to bear fruit. In its Q1 results, the company reported strong growth, particularly in Russia and Asia Pacific. The company's focus on digitalisation is central to our investment case and e-commerce grew 40 per cent. Earlier in the year, some slowdown in sales growth led us to test our investment case by commissioning a report from Grassroots Research, our proprietary market research division. Using on the ground interviews and big data web-scraping, the report found that this slowdown was due to Adidas exercising its pricing power over retailers, leading to improved margin and profitability. This has since been borne out in the results, with margins clearly rising and Adidas maintaining a positive outlook for 2019.

 

Iberdrola, the Spanish based power company, is delivering revenue and net income growth of 9 and 15 per cent, respectively. Renewables are a key growth area, and the company has seen pricing, production and capacity all rise as countries try to move away from fossil fuels. Looking ahead, the company is optimistic about full year earnings and dividends, aided further by lower debt and tax costs.

 

In Financials, our positions in Munich Re, Visa and Ashmore have all distinguished themselves by virtue of their ability to generate fee-based revenues. Visa in particular continues to benefit from a structural move away from cash, and its strategic investment in new payment technologies.

 

Conversely, stock selection in Industrials and Health Care sectors was weaker.

 

Wabtec detracted from performance. We believe this has been mostly driven by arbitrage around the closure of Wabtec's General Electric deal, as well as the relatively high leverage this incurred. However, as rail companies move towards Precision Scheduled Railroading (PSR), Wabtec's merger with GE makes it the leading Original Equipment Manufacturer (OEM) supplier of the most efficient diesel-electric locomotives in the world and thus well positioned to benefit from this modernisation. Moreover, while economic weakness remains a potential risk, industry order backlog remains strong. With the company expecting to reduce leverage to 2.5 times net debt / EBITDA* by the end of the year thanks to its strong free cash flow, the company looks oversold.

 

UnitedHealth Group has had the largest negative impact on returns over this period. Shares in the integrated healthcare provider weakened following calls for universal state provision from US Democrats in the run up to 2020's presidential election.  We regard this as a very low probability event and more of an excuse for profit-taking given the company's success in recent years. We believe that some reform of drug pricing and rebates is likely to emerge, and that rhetoric is likely to rise over the next year. However, we view the concerns towards the healthcare providers, who are drivers of lower healthcare costs, as overdone. Indeed, the stock has rebounded with recent results showing strong growth in premiums, services and products, with healthy medical loss ratios and good cost control.

 

*Earnings before interest, tax, depreciation and amortisation

 

Significant Transactions

Overall we have continued the strategic shift in the portfolio, concentrating the holdings on higher conviction, higher quality investments. The restructured balance sheet has provided higher dividend cover, allowing greater flexibility in stock selection.

 

Having monitored St James's Place for some time, we initiated a position in the UK financial services company in January. Brexit-induced weakness has made the shares increasingly cheap. However, the business has an exceptional growth record and there is substantial valuation support underpinned by its existing book of business.

 

In March, we initiated positions in Bright Horizons, Assa Abloy and Intuit. These are a provider of childcare and educational services, a manufacturer of door locking services and a developer of financial management software, respectively. Each company has demonstrated the ability to generate sustainable earnings growth at a time when this is in short supply and, at the time of purchase, the shares were reasonably valued.

 

More recently we have started a position in Intuitive Surgical, the manufacturer of the da Vinci surgical system.  Growth is being driven by new product launches and increased adoption of robotic surgery in different procedures beyond its traditional areas of Gynaecology and Urology.  A Grassroots study in the month showed strong intent among Chinese hospitals to buy or upgrade their systems, and a growing awareness of the product among surgeons and patients. The stock is likely to exhibit higher volatility than average but this is balanced by higher growth potential.  

 

To fund these new holdings, we have continued to exit positions with lower medium term conviction, using short term strength where possible. Greene King, the UK pub company, was held primarily for yield, while growth was pedestrian. However, the shares rallied sharply following a strong Christmas trading statement, so we used the recovery to exit our holding. Similarly Ameriprise and Apple were sold after sharp recoveries in the first quarter.

 

Across the portfolio, we have also taken advantage of several bouts of market volatility to increase positions in favoured stocks. In December, despite good overall numbers, slightly weaker new business figures for Accenture caused the consultancy firm's share price to decline to overly pessimistic levels, so we took the position up. In January, we took the opportunity to add to TSMC, which was trading at a depressed valuation with earnings starting to stabilise.

 

 

 

Outlook

Monetary policy and trade are likely to remain key drivers of market behaviour in the foreseeable future.

 

US/China trade tensions and tariffs have the potential for further negative impacts on growth. At the micro level, the more uncertain operating environment for the corporate sector is increasingly hindering decision making and reducing visibility on demand.  On balance, our base case assumption remains that some partial deal with be reached between US and China, potentially rolling back some of the recently increased tariffs. We are, however, expecting long term friction to feature in the technology sector with ongoing tension around state control, intellectual property and cyber security.

 

Global growth has slowed in the last six months as the stimulus from US tax reform faded and trade frictions hold back investment.  The considerable stimulus being applied in China should lead to stabilisation later this year, but domestic demand is weaker in the meantime. Within Europe, the recent elections, with no further shift towards populism, have removed some risk but growth remains sluggish. Italy continues to be a long term source of instability, as now does the UK.  

 

Monetary policy remains a source of uncertainty. In the US, the Fed has paused and is mulling over recent mixed data while conducting a major review of its tools, policies and communication methods, including what targets to aim for going forward. In Europe, the ECB also faces a potential shift when its President, Mario Draghi departs at the end of October. US ten-year treasury yields are at their lowest level in two years, lifting bond proxies in the equity markets as a result. Whether growth or value stocks are more likely to outperform in this event is a constant source of debate.

 

Our expectation of more moderate returns with higher volatility is therefore still a central case, with slight gains and considerable movement in between. With monetary policy on hold and optimistic rate expectations already embedded, earnings growth decelerating and valuations towards the upper end of historic ranges, there is no reason to expect equity markets overall to deliver strong nominal returns. Therefore, an active approach such as ours, driven by superior stock selection, is going to be required to provide additional upside.  

 

 

 

 

Lucy Macdonald

Allianz Global Investors

 

BRUNNER INVESTMENT TRUST PLC

INVESTMENT PORTFOLIO AS AT 31 MAY 2019

 

Listed Equity Holdings

Name

 

Value

£'000s

% of Invested Funds

Sector

Microsoft

17,763

4.51

Software & Computer Services

United Health

13,127

3.34

Health Care Equipment & Services

Royal Dutch Shell 'B' Shares

11,452

2.90

Oil & Gas Producers

Accenture

10,440

2.65

Support Services

Visa

10,108

2.56

Financial Services

The Cooper 

9,923

2.52

Health Care Equipment & Services

Ecolab

9,639

2.44

Chemicals

Muenchener Rueckver

9,407

2.39

Non-Life Insurance

Roche Holdings

9,087

2.30

Pharmaceuticals & Biotechnology

Taiwan Semiconductor

8,877

2.25

Technology Hardware & Equipment

BP

8,850

2.24

Oil & Gas Producers

Estée Lauder 'A' Shares

8,327

2.11

Personal Goods

Agilent

8,315

2.11

Electronic & Electrical Equipment

AIA

8,015

2.03

Life Insurance

Adidas

7,914

2.01

Personal Goods

GlaxoSmithKline

7,634

1.94

Pharmaceuticals & Biotechnology

AbbVie

7,244

1.84

Pharmaceuticals & Biotechnology

Amadeus

6,934

1.76

Software & Computer Services

Informa

6,601

1.67

Media

Unilever

6,578

1.67

Personal Goods

Schneider Electric

6,448

1.63

Electronic & Electrical Equipment

Compass

6,446

1.63

Travel & Leisure

AMETEK

6,435

1.63

Electronic & Electrical Equipment

Microchip Technology

6,418

1.63

Technology Hardware & Equipment

Itochu

6,221

1.58

General Industrials

Charles Schwab

6,045

1.53

Financial Services

HSBC

5,870

1.49

Banks

Nestle

5,714

1.45

Food Producers

Booking Holdings

5,690

1.44

Travel & Leisure

Iberdrola

5,524

1.40

Electricity

Cie Financiere Richemont

5,416

1.37

Personal Goods

Tyman

5,333

1.35

Construction & Materials

Senior

5,290

1.34

Aerospace & Defence

St. James's Place

5,230

1.33

Life Insurance

Rio Tinto

4,990

1.27

Mining

Prudential

4,733

1.20

Life Insurance

SThree

4,697

1.19

Support Services

Jiangsu Express

4,659

1.18

Industrial Transportation

Enel

4,649

1.18

Electricity

Citigroup

4,583

1.16

Banks

Amphenol

4,492

1.14

Electronic & Electrical Equipment

Ashmore

4,488

1.14

Financial Services

Sirius Real Estate

4,466

1.13

Real Estate

Partners Group

4,444

1.13

Financial Services

Wabtec

4,415

1.12

Industrial Engineering

Brambles

4,413

1.12

General Industrials

Howden Joinery

4,396

1.11

Support Services

 

 

 

Name

 

Value

£'000s

% of Invested Funds

Sector

Bright Horizons Family Solutions

4,335

1.10

General Retailers

EOG Resources

4,199

1.06

Oil & Gas Producers

United Internet

4,090

1.04

Software & Computer Services

Atlas Copco

3,881

0.98

Industrial Engineering

Intuit 

3,860

0.98

Software & Computer Services

Intuitive Surgical

3,826

0.97

Health Care Equipment & Services

Lloyds Banking Group

3,722

0.94

Banks

Assa Abloy

3,660

0.93

Construction & Materials

UBS

3,606

0.91

Banks

TP ICAP

3,567

0.90

Financial Services

Nielsen

3,554

0.90

Media

China Mobile

3,503

0.89

Mobile Telecommunications

Fresenius

3,480

0.88

Health Care Equipment & Services

Merlin Properties

3,422

0.87

Real Estate

Astellas Pharma

3,416

0.87

Pharmaceuticals & Biotechnology

Australia & New Zealand Bank

3,354

0.85

Banks

Covestro

2,942

0.75

Chemicals

Albemarle

2,766

0.70

Chemicals

Helical 

1,469

0.37

Real Estate

 

 394,392

     100.00

 

 

 

 

 

 

Unlisted Equity Holdings

 

 

 

Fintrust Debenture

4

-  

Financial Services

 

4

-  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

                 

 

 

 

 

                       

GEOGRAPHICAL ANALYSIS AS AT 31 MAY 2019

 

 

%

 

 

North America

39.44

United Kingdom

26.81

Europe

22.98

Pacific Basin

8.32

Japan

2.45

 

 

Total

100.00

 

 

 

SECTORAL ANALYSIS AS AT 31 MAY 2019

 

 

%

 

 

Financials

21.93

Industrials

21.06

Health Care

14.66

Technology

12.17

Consumer Goods

8.61

Consumer Services

6.74

Oil & Gas

6.20

Basic Materials

5.16

Utilities

2.58

Telecommunications

0.89

 

 

Total

100.00

 

 

 

SUMMARY OF UNAUDITED RESULTS

INCOME STATEMENT

for the six months ended 31 May 2019

 

 

Revenue

Capital

Total Return

 

£'000s

£'000s

£'000s

 

 

 

(Note 2)

Gains on investments held at fair value through profit or loss

-

9,227

9,227

Losses on foreign currencies

-

(52)

(52)

Income from investments

6,615

-

6,615

Other income

11

-

11

Investment management fee

(258)

(601)

(859)

Administration expenses

(340)

-

(340)

Profit before finance costs and taxation

6,028

8,574

14,602

Finance costs: interest payable and similar charges

(148)

(318)

(466)

Profit on ordinary activities before taxation

5,880

8,256

14,136

Taxation

(508)

-

(508)

 

 

 

 

Profit after taxation attributable to ordinary shareholders

5,372

8,256

13,628

Earnings per ordinary share (Note 1)

 

 

 

(basic and diluted)

12.58p

19.34p

31.92p

 

 

 

 

 

BALANCE SHEET

as at 31 May 2019

 

 

 

£'000s

 

 

Investments held at fair value through profit or loss (Note 3)

394,396

Net current assets

280

Total assets less current liabilities

394,676

Creditors: amount falling due after more than one year

(25,060)

Total net assets

369,616

 

 

Called up share capital

 10,673

Capital redemption reserve

 5,327

Capital reserves

336,741

Revenue reserve

16,875

Equity Shareholders' funds

369,616

 

 

Net asset value per ordinary share

865.8p

 

 

The net asset value is based on 42,692,727 ordinary shares in issue at 31 May 2019

 

 

 

SUMMARY OF UNAUDITED RESULTS

INCOME STATEMENT

for the six months ended 31 May 2018

 

 

Revenue

Capital

Total Return

 

£'000s

£'000s

£'000s

 

 

 

(Note 2)

Gains on investments held at fair value through profit or loss

-

10,156

10,156

Losses on foreign currencies

-

(72)

(72)

Income from investments

5,945

-

5,945

Other income

10

-

10

Investment management fee

(272)

(636)

(908)

Administration expenses

(349)

(1)

(350)

Profit before finance costs and taxation

5,334

9,447

14,781

Finance costs: interest payable and similar charges

(415)

(939)

(1,354)

Profit on ordinary activities before taxation

4,919

8,508

13,427

Taxation

(417)

-

(417)

 

 

 

 

Profit after taxation attributable to ordinary shareholders

4,502

8,508

13,010

Earnings per ordinary share (Note 1)

 

 

 

(basic and diluted)

10.55p

19.93p

30.48p

 

 

 

 

 

BALANCE SHEET

as at 31 May 2018

 

 

 

£'000s

 

 

Investments held at fair value through profit or loss (Note 3)

405,108

Net current assets

2,282

Total assets less current liabilities

407,390

Creditors: amount falling due after more than one year

(30,422)

Total net assets

376,968

 

 

Called up share capital

 10,673

Capital redemption reserve

 5,327

Capital reserves

  345,618

Revenue reserve

15,350

Equity Shareholders' funds

376,968

 

 

Net asset value per ordinary share

883.0p

 

 

The net asset value is based on 42,692,727 ordinary shares in issue at 31 May 2018

 

 

 

 

 

BALANCE SHEET

as at 30 November 2018

 

 

 

£'000s

 

 

Investments held at fair value through profit or loss (Note 3)

381,787

Net current assets

3,541

Total assets less current liabilities

385,328

Creditors: amount falling due after more than one year

(25,055)

Total net assets

360,273

 

 

Called up share capital

10,673

Capital redemption reserve

5,327

Capital reserves

328,485

Revenue reserve

15,788

Equity shareholders' funds

360,273

 

 

Net asset value per ordinary share

843.9p

 

 

The net asset value is based on 42,692,727 ordinary shares in issue at 30 November 2018

 

 

 

 

 

 STATEMENT OF CHANGES IN EQUITY

           

 

 

 

 

 

Called up

Share

Capital

£'000s

Capital Redemption Reserve

£'000s

 

Capital

Reserve

£'000s

 

Revenue Reserve

£'000s

 

 

Total

£'000s

 

 

 

 

 

 

Six months ended 31 May 2018

 

 

 

 

 

Net assets at 1 December 2017

 10,673

  5,327

337,110

 14,904

 368,014

Revenue profit

 -

 -

 -

 4,502

 4,502

Dividends on ordinary shares (Note 4)

                  -

 -

 -

(4,056)

(4,056)

Capital profit

                  -

 -

8,508

 -

 8,508

 

 

 

 

 

 

Net assets at 31 May 2018

             10,673

              5,327

345,618

15,350

376,968

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six months ended 31 May 2019

 

 

 

 

 

Net assets at 1 December 2018

 10,673

  5,327

328,485

  15,788

  360,273

Revenue profit

 -

 -

 -

  5,372

  5,372

Dividends on ordinary shares (Note 4)

                  -

 -

 -

(4,291)

(4,291)

Unclaimed Dividends

                  -

 -

-

6

6

Capital profit

                  -

 -

8,256

 -

8,256 

 

 

 

 

 

 

Net assets at 31 May 2019

             10,673

              5,327

336,741

16,875

369,616

 

 

 

 

 

 

 

 

 

 

 

CASH FLOW STATEMENT

 

 

 

 

Six months

 

Six months

 

 

 

ended

 

ended

 

 

 

31 May

 

31 May

 

 

 

2019

 

2018

 

 

 

£000's

 

£000's

Operating activities

 

 

 

 

 

Profit before finance costs and taxation

 

 

14,602

 

14,781

Less: Gains on investments at fair value through profit or loss

 

 

(9,227)

 

(10,156)

Add: Special dividends credited to capital

 

 

257

 

-

Less: Losses on foreign currency

 

 

52

 

72

Less: Overseas tax suffered

 

 

(508)

 

(417)

Increase in other receivables

 

 

(288)

 

(36)

Decrease in other payables

 

 

(96)

 

(31)

Purchases of fixed asset investments held at fair value through profit or loss

 

 

(35,004)

 

(32,244)

Sales of fixed asset investments held at fair value through profit or loss

 

 

31,365

 

23,312

Net cash inflow (outflow) from operating activities

 

 

1,153

 

(4,719)

 

 

 

 

 

 

Financing activities

 

 

 

 

 

Interest paid

 

 

(451)

 

(2,333)

Repayment of Stepped Rate Interest Loan

 

 

-

 

(18,200)

Dividends paid on cumulative preference stock

 

 

(11)

 

(11)

Dividends paid on ordinary shares

 

 

(4,291)

 

(4,056)

Unclaimed dividends

 

 

6

 

-

Net cash outflow from financing activities

 

 

(4,747)

 

(24,600)

 

 

 

 

 

 

Decrease in cash and cash equivalents

 

 

(3,594)

 

(29,319)

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents at the start of the period

 

 

11,133

 

30,998

Effect of foreign exchange rates

 

 

(52)

 

(72)

Cash and cash equivalents at the end of the period

 

 

7,487

 

1,607

 

 

 

 

 

 

Comprising:

 

 

 

 

 

Cash at bank

 

 

7,487

 

1,607

 

 

 

 

 

 

 

 

 

NOTES

 

Note 1

 

The returns per ordinary share have been calculated using a weighted average number of shares in issue of 42,692,727 (31 May 2018: 42,692,727 shares).

 

Note 2

 

The total column of this statement is the profit and loss account of the company.

 

All revenue and capital items derive from continuing operations. No operations were acquired or discontinued in the period.

 

Purchases for the half year ended 31 May 2019 were £35,004,000 (31 May 2018: £31,682,000) and sales for the half year ended 31 May 2019 were £31,365,000 (31 May 2018: £19,687,000).

 

Included in the cost of investments are transaction costs on purchases which amounted to £69,000 (31 May 2018: £29,000) and transaction costs on sales which amounted to £7,000 (31 May 2018: £8,000).

 

Note 3

 

Investments are designated as held at fair value through profit or loss in accordance with FRS 102 sections 11 and 12.  Investments are initially recognised at fair value, which is determined to be their cost. Subsequently, investments are revalued at fair value which is the bid market price for listed investments.

 

FRS 102 fair value hierarchy disclosures (March 2016) sets out three fair value levels.

 

Level 1: The unadjusted quoted price in an active market for identical assets or liabilities that the entity can access at the measurement date

 

Level 2: Inputs other than quoted prices included within Level 1 that are observable (i.e., developed using market data) for the asset or liability, either directly or indirectly

 

Level 3: Inputs are unobservable (i.e., for which market data is unavailable) for the asset or liability

 

As at 31 May 2019, the financial assets at fair value through profit and loss of £394,396,000 (30 November 2018: £381,787,000) are categorised as follows:

 

 Six months

 

 Year ended

 

 ended

 

30 November

 

31 May 2019

 

2018

 

 £'000s

 

 £'000s

Level 1

394,392

 

381,783

Level 2

-

 

-

Level 3

4

 

4

 

394,396

 

381,787

 

 

Note 4

 

In accordance with section 32 FRS102 ' Events After the end of the Reporting Period', dividends declared after the end of the reporting period shall not be recognised as a liability.

 

 

Dividends payable on ordinary shares in respect of earnings for each period are as follows:

 

 

Six months ended

31 May 2019

£'000s

Six months ended

31 May 2018

£'000s

Year ended

30 November 2018

£'000s

 

Final dividend 6.00p paid 5 April 2019 (2018: 6.00p)

2,562

2,562

2,562

First quarterly dividend 4.05p paid 27 July 2018 (2017: 3.50p)

-

-

1,729

Second quarterly dividend 4.05p paid 21 September 2018 (2017: 3.50p)

-

-

1,729

Third quarterly dividend 4.05p paid 14 December 2018 (2017: 3.50p)

1,729

1,494

1,494

 

4,291

4,056

7,514

 

Dividends declared after the period end are not recognised as a liability under section 32 FRS 102 'Events after the end of the reporting period'. Details of these dividends are set out below.

 

 

Six months ended

31 May 2019

£'000s

 

Six months ended

31 May 2018

£'000s

 

Year ended

30 November 2018

£'000s

First quarterly dividend 4.66p payable 25 July 2019 (2018: 4.05p)

1,989

1,729

-

Second quarterly dividend 4.66p payable 19 September 2019 (2018: 4.05p)

1,989

1,729

-

Third quarterly dividend 4.05p

-

-

1,729

 Final dividend 6.00p

       -

       -

                2,562

 

       3,978

3,458

4,291

 

 

The final and quarterly dividends above are based on the number of shares in issue at the period end. However, the dividend payable will be based upon the number of shares in issue on the record date and will reflect any purchase or cancellation of shares by the company settled subsequent to the period end.

 

 

Note 5

 

The directors believe it is appropriate to continue to adopt the going concern basis in preparing the financial statements, as the assets of the company consist mainly of securities which are readily realisable and accordingly, that the company has adequate financial resources to continue in operational existence for the foreseeable future.

 

Note 6

 

The half-yearly report has neither been audited nor reviewed by the company's auditors. The financial information for the year ended 30 November 2018 has been extracted from the statutory accounts for that year which have been delivered to the Registrar of Companies and restated by reference to the changes in the accounting policies detailed above. The auditor's report on those accounts was unqualified and did not contain a statement under either section 498(2) or (3) of the Companies Act 2006.

 

 

The half-yearly financial report will be sent to shareholders in late July 2019 and will be available to members of the public from the company's registered office at 199 Bishopsgate, London EC2M 3TY.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR LLFFDDLIDLIA
Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


Half-year Report - RNS